This review article focuses on mechanical properties and composition of degradable polymer, metal (magnesium), ceramic and composite materials with respect to clinical application involving cortical/cancellous bone, dentin and enamel, and ligament, tendon and fascia. On the basis of mechanical property comparison, each class of densified material may be used to substitute cortical bone, may not be used to substitute cancellous bone, may be used to substitute enamel and dentin, may be used to substitute lower limb ligaments and tendons, and may be used to substitute selected upper limb and trunk ligaments and associated tissues. For relatively longer times of recovery from more severe orthopedic trauma, PLLA (poly L-lactic acid) and TMC (trimethyl carbonate) polymers, selected Mg alloys containing zinc (Zn), calcium (Ca) and/or rare-earth (RE) elements, or hydroxyapatite (HA) and tricalcium phosphate (TCP) as crystalline bioceramics apparently are most suitable. Mg alloys or composites have significant potential for clinical application where the ability to bear appropriate load at least in the initial stages of recovery prior to significant resorption and load transfer to new tissue is critical. However, there is no clear opinion at present regarding the toxicity levels of many alloying elements in Mg alloys, particularly concerning RE elements. There is also the potential issue of nanoparticle cytotoxicity concerning alloy nanocomposite degradation invivo. Compared to crystalline bioceramics, the higher index of bioactivity (I B ) of amorphous glasses and glass ceramics reflects their superior ability to form a dense interphase and bond strongly with bone, despite their mechanical inferiority. The combination of bioceramic and biodegradable polymer is synergistic based on direct improvement of mechanical property and degradation resistance of the polymer, indirect reduction of foreign body interactions, and direct increase in toughness of the ceramic. Future directions of this field regarding developments on cellulose as a biodegradable material, bone tissue regeneration and engineering, stronger and more corrosion resistant and biocompatible magnesium alloy systems, applicable nanoparticles and nanotechnology, and soft tissue engineering such as vascular tissue engineering are also addressed.
INTRODUCTION
Biomaterials are used to make devices to replace a part or a function of the body in a safe, reliably economical, and physiologically acceptable manner. A variety of devices and materials are used in the treatment of disease or injury. Some of these devices remain in the body without significant degradation for extended lengths of time, e.g., titanium alloy based pacemaker and arthroplastic devices for the hip and knee joints. 1 2 There are also devices surgically removed after planned durations of implantation when the tissue has healed, e.g., various bone fixation plates and screws made of stainless steel. 3 4 Further, some devices may be left in the body to intentionally degrade during tissue healing, e.g., polymeric implants for meniscus repair, selected metallic (magnesium based) orthopedic screws and phosphate ceramic based bone inserts. 5 6 This last group of devices is of significant appeal based on the elimination of the surgical removal step (and significant reduction of surgical risk) towards complete healing.
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Seeram Ramakrishna PE, FREng is well known to the worldwide community of electrospinners and materials. He advances science and engineering of nanomaterials for innovations in areas of societal importance. He is a professor of materials engineering and Director of Center for Nanofibers and Nanotechnology at the National University of Singapore. He is a Highly Cited Materials Scientist. He authored 11 books and ∼1000 journal papers which attracted ∼44,000 citations and 98 H-index (with 470 i10-Index). He is on the editorial boards of ∼10 international journals. Companies Biomers (http://simpliclear .com/), Electrospunra (http://www.electrospunra.com/#page_2/) and Electrospin Tech (http://electrospintech.com/) have roots in the technologies nurtured at his labs. He levels of mechanical stress compared to regions further away from the implanted device. The degradation of polymer, metal and ceramic under physiological conditions is also different for each class of material. Polymers tend to degrade invivo due to ionic attack, oxygen dissolution, enzyme attack and hydration, implying the lower stability of hydrophilic polymers compared to hydrophilic polymers. 11 12 Chain scission in the polymer backbone mechanizes the degradation. Polymer degradation effects invivo include undesirable tissue reactions when the degradation rates are high. Metals degrade invivo primarily according to corrosion mechanisms involving metal ion release. 13 14 Excessive corrosion rates contribute to high metal ion uptake by tissue adjacent to the metal implant device. The high metal ion uptake generally leads to undesirable adjacent tissue reactions. Ceramics degrade invivo by leaching of selected network forming elements. 15 16 The leaching also involves ion formation from the elements and excessive ion uptake also similarly leads to undesirable adjacent tissue reactions.
The key to successfully designing invivo biodegradable implant devices involves (in part): (1) tailoring of mechanical properties and (2) effective regulation of degradation of the material(s) used in the implant device.
It is also necessary to understand the physiology of the body as well as patho-physiological response of the body to various elements, linked to short term as well as long term effects of degradable device implantation. 17 18 This review article focuses on mechanical properties and composition of degradable polymer, metal (magnesium), ceramic and composite materials with respect to clinical application involving cortical/cancellous bone, dentin and enamel, and ligament, tendon and fascia.
BASIC MECHANICAL PROPERTIES OF CORTICAL/CANCELLOUS BONE, DENTIN AND ENAMEL, AND LIGAMENT, TENDON AND FASCIA
In cortical bone, secondary osteons are roughly cylindrical structures that are typically several millimeters long and around 0.2 mm in diameter. There are longitudinal osteons and alternate osteons whose collagen fibers are longitudinally oriented and non-longitudinally (i.e., alternately) oriented, respectively. [19] [20] [21] Table I lists the elastic moduli and strengths of longitudinal osteons and alternate osteons. Generally, bending modulus is lowest while torsional modulus is highest, and bending strength is overall highest compared to strengths in other deformation modes.
In cancellous bone, also known as trabecular or spongy bone, there are lamellar bone packets of rod and plate arrays that make up interconnected passages which are filled with bone marrow. 21 Table II lists the moduli and compressive strengths of cancellous bone. Having a heterogeneous open cell porous structure, cancellous bone exhibits anisotropic mechanical properties that depend on porosity and architectural arrangement of 21 22 Enamel and dentin pertain to teeth, i.e., incisors, canines, premolars and molars, which are used for cutting, tearing, grasping and grinding food, respectively. Teeth are structurally heterogeneous where harder and stronger enamel coat softer yet tougher dentin, where there is the dentino-enamel-juction (DEJ) as the interphase. 21 23 Table III lists the basic mechanical properties of enamel and dentin. Generally, modulus and strength of enamel in molars is highest, and modulus and strength of dentin is comparatively invariant.
Ligament, tendon and fascia consist primarily of collagen fibers. Ligament connects bone to bone, tendon connects muscle to bone, and fascia is a sheet of fibrous tissue which encloses muscle. In ligaments and tendons, the collagen fibers are in aligned bundle packs whereas in fascia, there may be no dominant alignment of collagen fibers. 21 24 25 Tables IV and V list the basic mechanical properties of lower limb ligaments, tendons and fascia, and upper limb and trunk ligaments and associated tissues, respectively. Generally, the ligaments and associated tissues in the lower limbs tend to have higher modulus, higher strength and lower strain at ultimate strength, compared to the ligaments and associated tissues in the upper limbs.
BIODEGRADABLE POLYMERS
The main biodegradable polymers applicable to clinical applications are poly(lactic acid) PLA, poly(glcolic acid) PGA and PLA/PGA copolymers. [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] Other polymers include collagen, poly (hydroxybutyrate) PHB, polycarbonates derived from desaminotyrosyl-tyrosine ethyl ester DTE, cellulose acetate CA, polydioxanone PDS, polycaprolactone PCL, polyphosphazines, chitin or chotosan, poly(ethylene glycol) PEG, poly(vinyl alcohol) PVA, polyethylene oxide-polybutylene terephthalate PEO/PBT copolymer, and polypropylene fumarate (PPF). [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] Collagen is a major component of tissue and accounts for 30% of protein in the body. Every tissue requiring strength and flexibility has collagen and there are many forms of collagen in the body. Generally, collagen consists of triple helix formed proteins spanned across a significant portion of the molecule. The molecules may easily polymerise into fibers or larger structures and may also be further modified with intra/inter-molecular links to form the macroscopic fibers, fibrils, and bundles to form tissue. Disadvantageously, cross linking generally leads to lower deformability and increases tendency towards calcification. 50 Chitosan is the deacylated derivative of chitin, which is a naturally occurring polysaccharide. The residual acetyl content determines the biodegradation rate of chitosan and can be easily tailored during synthesis, enabling easy synthesis of chitosan with varied degradation rates. The chitosan macrostructure is sensitive to pH. It forms a gel above a pH of 6 in the presence of phosphate ions, and may form polyelectrolyte complexes with proteins and polysaccharides for use in controlled drug delivery applications. Other bioapplications include encapsulation, membrane barriers, contact lens material, and inhibitors of blood coagulation as opposed to heparin. 51 Chemically modified chitosan is a well tolerated implant material especially in tissue regenerative therapy.
Polyhdroxybutyrate (PHB) is a very simple form of polyhydroxyalkanoate (PHA). PHB is a storage polymer in organisms where its role is to store carbon dioxide and energy. PHB is highly crystalline, very brittle, hydrophobic, and easily undergoes hydrolytic or enzymatic degradation. However, PHB degradation invivo can take years. When PHB contains hydroxyvaleric acid, it is less crystalline, more flexible, and therefore may be more easily processed. PHB degrades invivo to a natural component of blood so is considered to have low toxicity. PHB has been used in controlled drug release applications, including sutures and artificial skin. 48 Polylactic acid (PLA), polyglycolic acid (PGA), and derived copolymers have been extensively used as safe synthetic biodegradable polymers in a variety of clinical applications. PLA, PGA and derived copolymers are the benchmarked biopolymers in the biomedical industry. PGA is highly crystalline, has a high melting point, and has low solubility in organic solvents. It is commercially available under the name Dexon, and was first implemented as biodegradable sutures 4 decades ago. PLA is more hydrophobic than PGA and was copolymerized with it for more biomedical industrial applicability. Copolymer sutures include Vicryl and Polyglactin 910. Interstingly, the high hydrophobic nature of PLA and highly crystalline nature of PGA are both lost when combined to form copolymers. PGA/PLA copolymers generally have lower crystallinity and hydrophobicity compared to the individual polymers, regardless of mixing ratio, and degrade during clinical use more rapidly than the individual polymers. Being esters, the degradation causes localized pH drop which may auto-accelerate the degradation and induce inflammatory response. [58] [59] [60] However, even when the degradation is controlled to avoid this disadvantage, another disadvantage is the non-robust but rather weak nature of porous structure arising from PGA/PLA copolymerization which limits use in hard tissue regeneration. There has been focus on PLA and PLA/PGA plates and screws for bone fixation, taking these disadvantages into account. 36 37 43 48 PLA/PGA based polymers may be processed by standard injection and compression molding but melt crystallization during processing leads to inferior mechanical strength. 32 36 Self-reinforcing (SR) techniques have been used, namely sintering and fibrillation, to increase mechanical strength leading to better clinical applicability. 61 62 SR processed PLA and PLA/PGA systems have found application as orthopedic plates and screws under the Biofix tradename. 63 Polycaprolactone (PCL) is a semicrystalline polymer with a low melting point and low glass transition temperature. PCL also has high thermal stability and easily forms blends with a wide range of polymers. PCL degrades at a slower rate compared to PLA and can be used in drug delivery devices active for a year. PCL is considered nontoxic and tissue compatible, and is often used as a tissue scaffold. [52] [53] [54] Polydioxanone (PDS) has poor mechanical strength, 55% crystallinity, and a glass transition temperature slightly below 0 C. It cannot be used for manufacturing medical implants. PDS does not exhibit acute toxic effects, but resorbs within 6 months, making it compatible as dressing for slow-healing wounds. 48 Polyethylene oxide-polybutylene terephthalate PEO/PBT copolymer have been investigated for bone replacement applications. Weighting of each component allows controlled determination of mechanical properties and degradation characteristics towards good bone bonding behavior based on favorable hydrogel properties. For soft tissue applications like skin scaffold, suitable mechanical properties and good biocompatibility invitro and invivo have been demonstrated. 64 Polypropylene fumarate (PPF) is viscous at room temperature but may be cross-linked with N-VinylPyrolidone (N-VP) releasing low amounts of heat to form putty prior to injection or molding into the bone defect of complex geometry. This is considered near net shape processing during surgery where compared with other forms of polymerization, the heat released during putty formation and injection/molding is significantly lower, therefore reducing the risk of local tissue necrosis as observed invivo. 55 Table VI lists the mechanical properties and degradation data of biodegradable polymers. Compared with Tables I-V, based on basic mechanical properties, most polymers in Table VI may be used to substitute cortical bone, may not be used to substitute cancellous bone, may be used to substitute enamel and dentin, may be used to substitute lower limb ligaments and tendons, and may be used to substitute selected upper limb and trunk ligaments and associated tissues. (4) 14 (6) 14 (0.7) 12 (2) 9.7 (2) 12 (3) osteofixation. This reinforces the logic behind which type of polymer to use for clinical osteo-applications, depending on intended duration of patient recovery. Apparently, PLLA (poly L-lactic acid) and TMC (trimethyl carbonate) are best suited for longer durations of patient recovery while PGA (poly glycolic acid) and PDS (poly dioxanone) are best suited for relatively shorter durations of patient recovery. 
BIODEGRADABLE METALS (MAGNESIUM ALLOYS)
Magnesium (Mg) is the central atom in the photosynthesis process occurring in all plants under sunlight containing the green pigment chlorophyll, making it one of the main building blocks of nature next to carbon and silicon. In parallel fashion, as the lightest structural metal known to man, magnesium has valuable application in the aerospace, automotive, consumer electronics, sports and recreational, and very importantly defence industries. 65 In comparison, recent studies have cited Mg and its alloys as potential materials for biomedical applications. [66] [67] [68] [69] [70] [71] [72] [73] [74] The advantages Mg-based materials possess include apparent non-toxicity, biocompatibility, mechanical compatibility with bone, and biodegradability in the body. 75 Concerning good biological behaviour, Mg is an essential element for the human body. Being the fourth most abundant cation in the human body, Mg 2+ is stored mainly in bone tissue. Mg 2+ is the direct corrosion product of magnesium, is absorbed by the human body easily, and can be excreted in urine. 75 Concerning good mechanical properties, Mg based metals have advantage over the currently developed biodegradable materials such as polymers and ceramics (including bioactive glasses) in load bearing applications requiring higher strengths. Mg also has Young's modulus similar or close to that of bone (in the 20-40 GPa range), compared with titanium (Ti) alloys (about 110 GPa), stainless steel (SS) alloys (about 200 GPa) and cobalt (Co) based alloys (about 230 GPa). This generally mitigates or minimizes the stress shielding effect induced by serious mismatch in modulus between natural bone and metal implant. The density of Mg (1.74 g/cc) is also close to those of natural bone (1.8-2.1 g/cc), compared with Ti alloys (4.42 g/cc for Ti-6Al-4V), SS alloys (about 7.8 g/cc), biodegradable polymers (about 1 g/cc for PLLA) and hydroxyapatite (3.16 g/cc).
Regarding metallurgical categories of Mg alloys, ZK60A (Mg-6Zn-0.5Zr) is commonly used in structural applications based on: (a) high strength and ductility after T5 aging, (b) good creep resistance, (c) poor arc weldability due to hot-shortness cracking and (d) excellent resistance weldability. 65 Overall, Mg-Zn alloys are well known for their precipitation hardening characteristics during ageing. 65 During precipitation hardening, MgZn' (or metastable 1 ' phase) forms as rods parallel to the c-axis of the HCP unit cell while metastable 2 ' phase forms as discs parallel to the (0 0 0 2) basal plane of the HCP unit cell. [76] [77] [78] [79] [80] It has been reported that the 1 ' phase has a monoclinic structure similar to that of Mg 4 Zn 7 in aged Mg-8 wt.% Zn alloy. 76 Also, the yield strength of quasicrystalline particle reinforced Mg-Zn-Y and Mg-Zn-Y-Zr magnesium alloys was observed to increase with the volume fraction of the quasicrystalline phase based on the strengthening effect of the quasicrystalline particles. 81 The icosahedral particles in the Mg-Zn-Y alloy have been observed to be stable against coarsening during elevated temperature deformation due to low particle-matrix interfacial energy. 81 Concerning the aluminium-zinc or AZ series of magnesium alloys, these alloys are characterized by: (a) low cost, (b) ease of handling, (c) good strength and ductility and (d) resistance to atmospheric corrosion. 65 Such characteristics enable the common use of AZ series magnesium alloys in weight-critical applications. 65 Mg-RE (Rare Earth) alloys are the latest metallurgical category of Mg alloys being developed. Currently, Mg-Y and Mg-RE alloys are in development for even more specific metallurgical advantages but at generally higher cost compared to Mg-Zn and Mg-Al alloys. 65 Compared to the rest of the conventional melt-processed magnesium alloy family (mainly Mg-Al and Mg-Zn based alloys), it is well-known that Mg-RE alloys have better elevated temperature strength retention characteristics. 65 This is due mainly to the higher melting point of the Mg-RE intermetallics present, meaning that these intermetallics commence going into solution only at higher temperatures. However, it is also well-known at present that long period stacking/ordered phases (LPSO phases) also reinforce (in atom percent) Mg 97 Y 2 Zn 1 type Mg-RE alloys. 82 Here, the LPSO phases are generally composed of a solid solution of Y and Zn atoms placed orderly in long periods along the Mg basal plane. 83 Compared to the temperature where Mg-RE intermetallics start going into solution, the LPSO phase starts losing order at higher temperatures closer to the liquidus temperature of the alloy. 84 This implies that the LPSO phase has even higher thermal stability compared to the Mg-RE intermetallic. The LPSO phase is also more chemically homogenous (down to atomic levels) compared to the Mg-RE intermetallic region of similar area, necessarily meaning that the LPSO phase is more corrosion resistant than the Mg-RE intermetallic region. Elevated temperature loss of strength and room temperature corrosion susceptibility are major durability and cost related disadvantages concerning magnesium alloy component usage that LPSO phase formation in selected Mg-RE alloys may negate. Mg-Gd-Y alloys are also known for good response to age hardening. 85 Mg-Gd-Y-Zr alloy has also been co-rolled with AA7075 series aluminium alloy (as cladding) towards good tensile response. 86 Table VII lists the mechanical properties of wrought and cast aluminium-zinc (AZ), zinc-zirconium (ZK), rare earth (RE) and other magnesium alloys. Compared with Tables I-V, based on basic mechanical properties, most Mg alloys listed in Table VII may be used to substitute cortical bone, may not be used to substitute cancellous bone, may be used to substitute enamel and dentin, may be used to selectively substitute lower limb ligaments and tendons, and may be used in limited manner to substitute selected upper limb and trunk ligaments and associated tissues.
Concerning corrosion resistance, it is well known that dissolved Cu readily binds with precipitating intermetallic phases in Mg alloys. 65 Such binding tends to regulate the precipitating intermetallic phases towards finer size, and increase the thermal stability of the intermetallic phase against dissolution into the alloy matrix, as well as corrosion resistance. A good example is ZC71 (Mg-6.5Zn-1.25Cu) where Cu mainly binds with Mg-Zn intermetallics. 65 Figure 1 shows the biodegradation characteristics of Mg alloys potentially suitable for clinical applications. 96 Mg(OH) 2 forms a stable protective layer on the surface of magnesium implants in high pH (>11.5) environments, but lower pH (<11.5) will facilitate corrosion of magnesium alloys in aqueous solution (see Fig. 2 ). 101 The local pH at the implant-bone interface is about 7.4 due to secondary acidosis resulting from metabolic and resorptive processes after surgery. 72 The Mg(OH) 2 layer is unable to adhere to and protect the implant surface under such conditions. Constant exposure to high chloride containing electrolyte of the physiological system causes accelerated invivo corrosion of the Mg implant. From Figure 1 , it is apparent that selected Mg alloys containing zinc (Zn), calcium (Ca) and/or RE elements experience relatively lower corrosion rates under physiological conditions invitro. Comparing the alloying elements on a binary system basis, gadolinium (Gd) is most effective in lowering the corrosion rate of Mg. The effectiveness of the alloying element in reducing Alloying elements (wt%)
Degradation rate (mm/y) Fig. 1 . Biodegradation characteristics of Mg alloys potentially suitable for clinical applications. 96 103 Shaded regions indicate desired corrosion or degradation rates. the corrodibility of Mg reflects the stability of the alloying element oxide in aqueous media.
The stability of the alloying element oxide in aqueous media reinforces the logic behind which Mg alloy to use for clinical osteo-applications, depending on intended duration of patient recovery. Apparently, selected Mg alloys containing zinc (Zn), calcium (Ca) and/or RE elements are best suited for longer durations of patient recovery while other Mg alloys in the same family are best suited for relatively shorter durations of patient recovery. However, there is no clear opinion at present regarding the toxicity levels of many alloying elements in Mg alloys.
Regardless of the duration taken by the Mg alloy implant to corrode invivo, it is desired that the corrosion occurs in a stable and predictable manner, like in uniform corrosion. This is best achieved by including an alloying element whose native oxide film easily forms and adheres to the magnesium substrate without significantly deteriorating and flaking off. This is also best achieved by including an alloying element which forms fine second phase precipitates with the Mg matrix. Second phase precipitates are cathodic respective to the alloy matrix and coarser precipitates contribute to increased micro-galvanic corrosion. This is where RE elements have a significant advantage over other alloying elements. RE elements are known to form stable oxide films easily and also form fine second phase precipitates. Syntellix AG and the Hannover Medical School in Germany have designed the MgYREZr based Magnezix cannulated compression screw for orthopaedic applications where a Phase I clinical trial has been recently successful. 94 102 It is unclear if any surface coating (e.g., MgF 2 , apatite, carbonate etc.) exists for the Magnezix medical device. The nature of RE element used also needs more discussion. LAE442 is another Mg-RE alloy where more stable corrosion has been observed invivo. 73 However, a mix of rare earths known as mischmetal or didymium was used. Mischmetal and didymium can each differ in composition depending on the time and/or date of purchase. Mischmetal is cerium (Ce) based with additions of lanthanum (La) and neodymium (Nd) while didymium is Nd based with addition of praseodymium (Pr). 65 103 For reliable reproduction of this Mg-RE alloy, Ce or Nd were used to primarily replace the mischmetal or didymium mixtures. 92 93 Interestingly, LANd442 exhibited stable corrosion characteristics (however not as stable compared to LAE442) while LACe442 exhibited unstable corrosion characteristics.
Regarding toxicity levels of RE elements, short-term effect of RE elements invitro were evaluated. 104 Single RE elements were added to different cell lines and the effects were assessed. Differences between light (La, Ce, Pr) and medium to heavy (Nd, Europium (Eu), Gd and Dysprosium (Dy)) RE elements were observed. Generally, light RE elements showed toxic effects at lower concentrations and it was concluded that La and Ce should be used only when absolutely necessary. Concerning long term effects of RE elements invitro as well as invivo, no systematic studies or trials have been completed. Significant RE exposure and effects among miners in RE mines located within Mongolia (China) have been documented. 105 In the human body, RE elements are known to accumulate in the liver, kidneys and bone without being metabolised.
BIODEGRADABLE CERAMICS
Bone is essentially composed of calcium based phosphates as the mineral phase and collagen as the organic binding phase. Calcium phosphate based bioceramics are the main group used clinically as biodegradable ceramics. Bioceramics are used to fill tooth and bone defects, fix bone grafts, fractures and prostheses, and replace diseased (e.g., cancerous) tissue. Based on reaction with host tissue, bioceramics are bioactive and most are resorbable, encouraging and allowing replacement by bone and organic tissue at the site of injury. The similarities between the bone mineral phase and the structural and surface features of the bioceramics enable binding to bone without formation of undesirable fibrous connective tissue interface. 106 107 The most commonly used bioceramics are hydroxyapatite (HA, Ca 10 (PO 4 6 (OH) 2 , -tricalcium phosphate ( -TCP, Ca 3 (PO 4 2 ), derivatives as well as combinations. These are crystalline bioceramics. Densified HA is chemically most stable and the least resorbable invivo compared to the other bioceramics. While the other bioceramics are completely resorbed after implantation into the injured bone site, densified HA may remain integrated into the regenerated bone or slightly resorbed over time. 108 109 There is also a range of calcium phosphates that are injectable and harden within the bone cavity without releasing too much heat and causing premature death of surrounding cells. 110 111 HA has been used to fill small bone defects after bone tumour resection or after bone loss in fresh fractures but there has been comparatively less indication of HA being used to fill large bone defects. 112 Slow degradation of HA and minimal resorption after a 12 week implantation period in rabbit's femora has also been reported. 113 Compared to crystalline bioceramics such as HA, -TCP, derivatives as well as combinations, there are also amorphous bioglasses and glass-ceramics comprised mainly of CaO, Na 2 O, SiO 2 and P 2 O 5 . [114] [115] [116] The main advantage bioglasses and glass-ceramics have over crystalline bioceramics is that even though they are mechanically weaker and resorb faster than crystalline bioceramics, they form a dense and strong interface with natural bone up to 3 times faster than crystalline bioceramics. 117 Silicon (Si) in biological ceramics and glasses has a significant effect in the bone regeneration process. Compared to nondoped apatites, Si has been incorporated into apatites to induce the formation of a higher amount of bone tissue. 118 Here, Si was observed to improve bioactivity of apatite by forming Si-OH groups on the material surface. The Si-OH groups triggered the nucleation and formation of apatite layers on the surface improving the material-bone bonding characteristics. Generally, SiO 2 is the network former while CaO, Na 2 O and P 2 O 5 act as modifying agents in bioglasses and glass-ceramics. shows the compositional dependence of bone bonding to glass. 21 The index of bioactivity or I B listed in Table VIII is a measure of how active the bioceramic is toward dense interphase formation with natural bone at the site of injury. Briefly, I B indicates how fast (relatively) the bioceramic may be capable of forming the dense interphase with natural bone. Due to lower crystalline form, the bioglasses and glass-ceramics have higher I B than crystalline bioceramics, but tend to be mechanically weaker than the crystalline bioceramics as listed in Table VIII. Compared with Tables I-V, based on basic mechanical properties, densified HA, TCP, Ceravital, Cerabone A/W and Biovert (as listed in Table VIII) Table VIII may be used to substitute cortical bone, may not be used to substitute cancellous bone, may be used to substitute enamel and dentin, may be used to selectively substitute lower limb ligaments and tendons, and may be used in limited manner to substitute selected upper limb and trunk ligaments and associated tissues. The I B value of the bioceramic reinforces the logic behind which bioceramic to use for clinical osteo-applications, depending on intended duration of patient recovery. Crystalline bioceramics like HA and TCP having relatively lower I B are best suited for longer durations of patient recovery while amorphous glasses like 45S5 and S45PZ and glass ceramics like Ceravital, Cerabone A/W, I1mappant and Biovert having relatively higher I B are best suited for relatively shorter durations of patient recovery. This is especially the case even when the non-densified forms of bioceramics, such as porous structures or powders having higher specific area per unit volume for chemical interactions, are inserted into bone cavities for repair. MgO, TiO 2 (anatase) and K 2 O have also been used as network modifiers in amorphous bioglass and glass ceramic. [119] [120] [121] Bioglass surfaces have also been modified to further enhance their bioactivity by coating them with adhesive proteins to promote cell adhesion. 122 Clinical uses of amorphous glass and glass ceramic so far include filling materials in benign tumor surgeries, 123 reconstruction of defects in facial bones, tympanoplastic reconstruction, 126 lumbar fusion, 127 treatment of periodontal bone defects, 128 129 repairing orbital floor fractures, 125 130 obliteration of frontal sinuses, [131] [132] [133] reconstruction of the iliac crest defect after bone graft harvesting, 134 and repairing orbital floor fractures. 125 130 Reports on clinical applications are found for Depuy Spine Conduit ® (TCP), Medtronic MasterGraft ® (HA, TCP), Stryker Vitoss ® (TCP), Synthes ChronOS ® , Norian SRS ® (calcium phosphate), Stryker Cortoss ® (bioactive glass), etc. Synthetic HA has good compatibility with tissue but is clinically limited due to moderate resorbability invivo and mechanical properties that differ from surrounding tissues and bones. 135 With the aim of enhancing mechanical properties and bioactivity, there have been efforts to dope HA with magnesium (Mg), 115 strontium (Sr), 136 silicon (Si), 137 and carbonate (CO 2− 3 ). 138 HA has also been doped with silver (Ag) for curing infected bone defects. 139 
BIODEGRADABLE COMPOSITES
Bioceramics and biodegradable polymers have been combined into biodegradable composite pastes that may be injected into bone cavities for orthopedic applications. [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] Hydroxyapatite (HA) and tricalcium phosphate (TCP) have improved the osteoconductivity and bone bonding of the host polymer. [140] [141] [142] [143] Since HA and TCP resorp in basic conditions, any acidic degradation products released during polymer matrix degradation may be pH buffered, enabling foreign body reaction minimization. 144 145 The ceramic reinforcement may also act as a hydrolysis barrier, further delaying degradation of the polymer matrix. 146 Interestingly, auto-generated increase of local acidity due to degradation of poly(lactic acid) (PLA) for example may enhance solubility of the HA or TCP ceramic that may be used in new bone formation. 147 Polycaprolactone (PCL) has also been combined with calcium phosphate based reinforcement toward the same effect. 148 Concerning mechanical properties, there have been reports of calcium phosphate based reinforcements increasing stiffness and strength of the host polymer while also altering the rheological or viscous flow properties of the host polymer intended for injection into bone cavities. [149] [150] [151] [152] Fast setting calcium phosphate cements (CPCs) are also another example of biodegradable composite. 153 154 These cements set within the bone cavity when injected near body temperature and avoid thermally damaging surrounding tissue. Chitosan has significant pharmacological benefits for bone formation and has been reported as a component of CPCs. 155 Poly(propylene fumarate) (PPF) was developed with TCP and CaCO 3 fillers. This injectable composite hardened in 24-36 hrs, had mechanical properties much higher than human cancellous bone, and was sufficiently workable to be packed into bone defects of complex shape. 156 Apart from injectable polymer-based or ceramic-based biodegradable composites, biodegradable composites have been used in medical applications where stiffness and strength is low, e.g., tissue scaffolds. However, concerning significant clinical application for implantable biodegradable material systems, the ability to bear appropriate load at least in the initial stages of recovery prior to significant resorption and load transfer to new tissue is critical. This is exactly where biodegradable Mg alloys or composites have significant potential for clinical application. Table IX lists the mechanical properties of wrought, sintered and cast aluminium-zinc (AZ), zinc-zirconium (ZK), rare earth (RE) and other magnesium nanocomposites and microcomposites. 89 91 157-178 Compared with Tables I-V, based on basic mechanical properties, most Mg alloy nanocomposites and microcomposites listed in Table IX may be used to substitute cortical bone, may not be used to substitute cancellous bone, may be used to substitute enamel and dentin, may be used to selectively substitute lower limb ligaments and tendons, and may be used in limited manner to substitute selected upper limb and trunk ligaments and associated tissues. An attractive feature of wrought Mg alloy nanocomposites is the high ductility (>15%, >20%, >25%) in selected formulations. The high ductility may permit cold working to be performed to further increase strength at the expense of some of the excess ductility. However, it is probable (though not confirmed) that such further strengthening may worsen the corrosion behavior invivo. In the as-extruded or stress-relaxed state, it has been often shown that the nanoparticle additions to the different Mg alloys regulate the precipitation of second phase particles towards nanosize. 89 91 157-171 This breaks up surface cathodic sites and overall improves corrosion resisstance. 179 Concerning Mg microcomposites, it has been reported that the microparticle reinforcement deteriorates the invitro corrosion characteristics of the composite. [172] [173] [174] [175] [176] [177] [178] Another issue with the Mg alloy nanocomposites is the potential cytotoxicity of the exsitu added and/or second phase nanoparticles that may enter the body's circulatory system during invivo degradation of the biodegradable implant. 180 These nanoparticles may accumulate over time in different parts of the body, and because of the abundant and activated tight surface area inevitably interfere with selected cell based functions, or even affect genetic related material in the body causing hereditary changes. Provided the total concentration of nanoparticles in the alloy nanocomposite is 3 vol% and the nanoparticles are about 50 nm in diameter and well dispersed into the body's circulatory system during implant degradation, assuming 2 years complete degradation time for a 10 cm long alloy nanocomposite rod of 8 mm diameter that is inserted at the damaged tissue site, as many as 2 304 × 10 17 or 3 826 × 10 −7 moles of nanoparticles may be in circulation throughout the course of the 2 year recovery time. Like the rare earth alloying elements discussed earlier in the biodegradable metal (magnesium) section, the nanoparticles may remain [158] 190 ± 13 307 ± 10 17.5 ± 2.6 Extruded AZ31/AA5083/1.0vol%CNT [159] 221 ± 4 321 ± 1 12.0 ± 1.0 Extruded AZ31/AZ91/1.5vol%Al 2 O 3 [160] 232 ± 13 339 ± 10 15.9 ± 0.5 Extruded AZ31/AZ91/1.5vol%TiC [161] 236 ± 8 337 ± 7 14.5 ± 0.7 Extruded AZ31/AZ91/1.5vol%Si 3 N 4 [162] 232 ± 2 331 ± 2 1 3 . 1 ± 0.5 Extruded AZ81/1.5vol%Al 2 O 3 [163] 212 ± 12 339 ± 11 13.1 ± 1.0 Extruded AZ81/1.5vol%CNT [164] 209 ± 9 328 ± 4 1 3 . 7 ± 2.2 Extruded AZ81/1.5vol%Si 3 N 4 [165] 229 ± 9 328 ± 7 1 0 . 7 ± 0.9 Extruded AZ91/ZK60A/1.5vol%AlN [166] 236 ± 6 336 ± 4 13. unmetabolized in the body in the long term, enabling various acute or chronic effects.
FUTURE DIRECTIONS
Future directions of this field involving biodegradable materials include developments on cellulose. Bacterial cellulose has been physically modified to guide calcium phosphate precipitation from simulated body fluid. 181 182 Highly porous composite scaffolds for trabecular bone regeneration have also been successfully synthesized using hydroxypropyl-methyl-cellulose. 183 Bamboo pulp (as a reliable source) has been mechanically defibrillated to yield cellulose nanofibrils for medical applications. 184 Cellulose acetate nanofibers have also been electrospun into functional webs, where pH and hydroxyapatite nanoparticle content were each varied to enhance invitro bioactivity in simulated body fluid. 185 Cellulose contains lignin which may prove challengable to electrospin unless mixed in a solution with polyacrylonitrile. 186 Well dispersed lignin nanoparticles have also been synthesized in an environmentally friendly and upscalable manner using acid precipitation technology. 187 Directly relevant to bone tissue regeneration and engineering, the evolution of scaffolds as bone graft substitutes in the process of recreating the bone tissue microenvironment, including biochemical and biophysical cues has been reviewed. 187 The most common form of bone graft is the autograft but its use can lead to complications such as pain, infection, scarring, blood loss, and donor-site morbidity. The alternative is allografts which lack the osteoactive capacity of autografts and carry the risk of carrying infectious agents or immune rejection.
Other approaches, such as the bone graft substitutes, have focused on improving the efficacy of bone grafts or other scaffolds by incorporating bone progenitor cells and growth factors to stimulate cells. 187 Also, the microstructures and phase compositions of artificial and bone-derived hydroxyapatites (HAs) have been compared. 188 Bonederived HA was observed to consist mainly of HA and a small amount of MgO. Hot-pressed HA compacts showed homogeneous microstructures and densities of 95-97% but grain sizes and microstructures varied with the starting powders. Self-assembling peptide nanofiber scaffolds have also been developed for bone tissue engineering. 189 Concerning resorbability of HA, barium and fluorine have been observed to increase the invitro resorbability of synthetic HA. 190 The magnetic and morphological properties of ferrofluid-impregnated hydroxyapatite/collagen scaffolds have also been reported, where sufficient magnetization was used to attract potential magnetic carriers for transporting bioactive agents which favoured bone regeneration. 191 The osteoblast attachment on HA scaffolds has also been increased by performing an air atmospheric pressure plasma jet pretreatment for drop-wise loading of dexamethasone. 192 Concerning magnesium alloys, addition of calcium (Ca) to increase tensile yield strength to 340 MPa based on increased hot rolling speeds (and recrystalization) has been reported. 193 For corrosion resistance, improved wear performance and reduced thermal transport behavior on the surface, the formation of nanostructured oxidic coatings on Mg alloys using plasma electrolytic oxidation (PEO) has also been reported. 194 Also, polymer encapsulation via RF plasma polymerization has been critically discussed towards tailoring biodegradability and biocompatibility of magnesium. 195 Nanoparticles and nanotechnology continue to fuel the future of many fields including this one. Polyurethane nanofibers containing aqueous extract of Grewiamollis Juss have been produced using electrospinning for enhanced antimicrobial effects against Escherichia coli ATCC 52922 (Gram negative) and Staphylococcus aureus ATCC 29231 (Gram positive) in liquid medium. 196 Conductive polymer nanofibers have also been electrospun into scaffolds for the pursuit of biomimetic extracellular matrix (ECM) structures for adhesion, proliferation, and differentiation of cells involving electrical stimuation. 197 Titania and polylactide (including composite) nanoparticles as well as fucoidan-chitosan nanospheres have been reported to have significant potential for drug delivery applications based on good biocompatibility and biodegradability. 198 199 Pyrolysis derived carbon matrix nanocomposites have also been observed to be sufficiently protective of magnetic nanoparticles (embedded) for biomedical application invivo. 200 Carbon nanotubes (CNTs) have been observed to increase cellular uptake of three-dimensional biomimetic collagen hydrogels. 201 Polycaprolactone scaffolds have also been critically reviewed. 202 Here, the incorporation of nanofillers or blending of polycaprolactone with other polymers has yielded a class of hybrid materials with significantly improved physical and chemical properties such as strength, porosity, microstructure, controllable degradation rates, and bioactivity that are important for tissue engineering. Concerning potential neuroprotection using Cerybrolysin Therapy, the role of functionalized magnetic iron oxide nanoparticles in the central nervous system (CNS) injury and repair has been studied. 203 The magnetic iron oxide nanoparticles were observed to be safe for the CNS in disease conditions when co-administered with cerebrolysin. The interaction of nanomaterials with human cells is the most important criterion for biomedical application and has been studied in detail. 204 Three common approaches have been suggested for nanomaterial mechanisms for cellular interaction and internalization: direct diffusion or disruption to the plasma membrane, endocytosis, and entry through ion channels and transporter proteins. The antimicrobial properties of nanobiomaterials containing silver and its salts have also been reported. 205 206 As a form of soft tissue engineering, vascular tissue engineering is tied in with hard tissue engineering forms such as bone tissue engineering concerning future trends. Polycaprolactone (PCL) micro/nanofibers have been electrospun into 2D scaffolds where cell culture results showed that the cells are not only attached to the scaffold but also integrated with it i.e., the cells are embedded into the PCL scaffold. 207 208 Small deformable Janus particles with zwitterionic nature smoothly transport through catheters and slowly form large aggregates with effective vascular occluding properties. In arterial embolization, embolic particles should be deformable for smoother injection and large enough for effective occlusion of arteries. The unique assembly behavior of Janus particles have been reported to possess significant potential in exceeding the contemporary limits of embolization technology. 209 
CONCLUSIONS
1. On the basis of mechanical property comparison, each class of densified material (polymer, metal (magnesium), ceramic, composite) may be used to substitute cortical
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Biodegradable Materials for Clinical Applications: A Review bone, may not be used to substitute cancellous bone, may be used to substitute enamel and dentin, may be used to substitute lower limb ligaments and tendons, and may be used to substitute selected upper limb and trunk ligaments and associated tissues. 2 . Concerning longer times of recovery from more severe orthopedic trauma, PLLA (poly L-lactic acid) and TMC (trimethyl carbonate) polymers, selected Mg alloys containing zinc (Zn), calcium (Ca) and/or rare-earth (RE) elements, or hydroxyapatite (HA) and tricalcium phosphate (TCP) as crystalline bioceramics apparently are most suitable. 3 . Concerning biodegradable alloys, Mg alloys or composites have significant potential for clinical application where the ability to bear appropriate load at least in the initial stages of recovery prior to significant resorption and load transfer to new tissue is critical. However, there is no clear opinion at present regarding the toxicity levels of many alloying elements in Mg alloys, particularly concerning RE elements. There is also the potential issue of nanoparticle cytotoxicity concerning alloy nanocomposite degradation invivo. 4 . Concerning bioceramics, the higher index of bioactivity (I B ) of amorphous glasses and glass ceramics reflects the superior ability to form a dense interphase and bond strongly with bone, despite mechanical inferiority to crystalline bioceramics. 5 . Concerning biodegradable composites, the combination of bioceramic and biodegradable polymer is synergistic based on direct improvement of mechanical property and degradation resistance of the polymer, indirect reduction of foreign body interactions, and direct increase in toughness of the ceramic. 6 . Future directions in this field include developments on cellulose as a biodegradable material, bone tissue regeneration and engineering, stronger and more corrosion resistant and biocompatible magnesium alloy systems, applicable nanoparticles and nanotechnology, and soft tissue engineering such as vascular tissue engineering.
